Abstract
CMV-Hyperimmunoglobulin Improves Early Outcome in Critically Ill Liver Transplant Patients by a Combination of Antiviral, Anti-Inflammatory and Positive Immunomodulatory Capabilities
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have